UiPath (NYSE: PATH), a global leader in agentic automation, today announced that it has achieved ISO/IEC 42001:2023 ...

Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not be well-established and traditional approaches to evidence generation cannot ...

If you're looking for companies quietly shaping the next wave of AI-driven productivity, UiPath deserves a closer look.

While AI is certainly a threat, there's one reason to believe that UiPath's future looks bright, and why the stock could ...

UiPath 's ( PATH +2.93%) business centers around automating and leveraging artificial intelligence (AI) to save users time.

The standing of UiPath among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ...

NEW YORK, September 30, 2025--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced a collaboration with NVIDIA to help enterprise customers fortify their ...

Shares of automation software company UiPath (NYSE:PATH) jumped 8.4% in the afternoon session after the stock's positive ...

UiPath (NYSE:PATH) shares surged more than 10% during Tuesday market action after the automation solutions company announced an array of new collaborations with Nvidia (NVDA), OpenAI, Snowflake (SNOW) ...

In this contributed article, Harikrishna Kundariya, co-founder, Director of eSparkBiz Technologies, discusses how generative AI is emerging as a revolutionary technology that is simplifying as well as ...

When you search for "RPA robotic process automation software companies," this is the very question that arises in your mind. This article will thoroughly answer all your confusions regarding RPA ...